Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics announces Regulatory Strategies for Gene Therapy Product Development webinar
08 févr. 2021 03h00 HE | Cytovance Biologics
OKLAHOMA CITY, Okla., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene...